Experience That Delivers
Collaborating with Pharmaceutical Companies to Boost Innovation and Enhance Operational Success
Founder
With a proven track record of success in the pharmaceutical and biotech sectors, I bring decades of experience in strategic leadership and operational excellence. I’ve played pivotal roles in building and transforming commercial strategy and marketing for products like SEROQUEL®, RITUXAN®, BYETTA®, OFIRMEV®, and NUEDEXTA®, contributing to major acquisitions and market leadership. As a consultant and advisor, I’ve guided companies ranging from innovative startups to large-cap multinationals, leveraging deep expertise in business development, clinical advancements, and market strategy. As a patient and pharmaceutical company founder, I am working to transform treatment and develop disease modifying drugs for Dupuytren’s disease. I specialize in crafting solutions that align with business goals and improve patient outcomes. I am here to help you navigate complexity, seize opportunities, and achieve lasting impact.
Services
We provide tailored services based on the unique needs of your company, product, and market. From commercial diligence support on a target asset to supporting a launch optimization initiative, we provide consulting and advisory to address your needs.
Commercial Strategy
Opportunity Evaluations: Market, Prescriber, Competitive Analysis; Strategic Development, Integration of New Data, Cross-Functional Coordination
Product Development
New Product Planning, Indication Prioritization, Target Product Profile (TPP) Development & Evaluation, Clinical & Regulatory Planning
Commercialization
Brand Strategy, Positioning, (re) Positioning, Brand Planning, Launch Planning & Execution, Brand Identity and Core Message(s) Platform Development, HCP Segmentation & Messaging
Advisory
Strategic Advisory Services Leveraging Extensive Commercial, Operational, and Start-Up Experience
Unlock Your Product’s Market Success
We welcome a brief discussion to see if we can support your needs and business goals.